Back to search

Article

The new generation hDHODH inhibitor MEDS433 hinders the <i>in vitro</i> replication of SARS-CoV-2

2020-12-07

Abstract excerpt

Identification and development of effective drugs active against SARS-CoV-2 are urgently needed. Here, we report on the anti-SARS-CoV-2 activity of MEDS433, a novel inhibitor of human dihydroorotate dehydrogenase (hDHODH), a key cellular enzyme of the de novo pyrimidines biosynthesis. MEDS433 inhibits in vitro virus replication in the low nanomolar range, and through a mechanism that stems from its ability to bl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a0f97b27-a83f-5b82-ab07-e8f73f31f86d
DOI
10.1101/2020.12.06.412759
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The new generation hDHODH inhibitor MEDS433 hinders the <i>in vitro</i> replication of SARS-CoV-2DOI 10.1101/2020.12.06.412759
Select a neighboring publication to make it the new centre.